SUBSCRIBE
SUBSCRIBE

Bankruptcy

Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
Bay Area’s diaDexus Files Chapter 7 Bankruptcy, Plans to Liquidate Assets, CFO to Step Down Immediately
June 10, 2016
 · 
2 min read
Deals
BIND Therapeutics’s Bankruptcy Filing Worries Developers Of Nanoparticle Cancer Drugs
May 24, 2016
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Bay Area’s KineMed Files for Chapter 11, Owes $1 Million+ to NIH, Gates and Others
May 13, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
North Carolina’s NephroGenex Files for Chapter 11 and Seeks Sale
May 2, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Cambridge’s BIND Therapeutics Files for Chapter 11 and Reviews Strategic Alternatives
May 2, 2016
 · 
3 min read
Deals
Lesson From Turing’s Martin Shkreli: Pharmas Need To Walk Before They Can Talk
December 30, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Martin Shkreli’s Former Drugmaker KaloBios Files for Bankruptcy
December 30, 2015
 · 
4 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Deals
SoCal’s Laguna Shuts Down After Heart Drug Presents Unseen Safety Concerns
December 7, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Once Promising Bay Area KaloBios to Shut Down, Liquidate Assets
November 16, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
SoCal Biotech AtheroNova and its Subsidiary File for Chapter 11
March 3, 2015
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
December 30, 2024
 · 
5 min read
Press Releases
BIOLASE Voluntarily Initiates Chapter 11 Proceedings
October 1, 2024
 · 
6 min read
Deals
DermTech Files for Voluntary Chapter 11 Protection
June 18, 2024
 · 
5 min read
Deals
Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
April 18, 2024
 · 
1 min read
Deals
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
April 1, 2024
 · 
8 min read
Deals
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
April 1, 2024
 · 
3 min read
Deals
Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process
February 13, 2024
 · 
6 min read
Deals
Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
February 13, 2024
 · 
6 min read
Deals
Potrero Medical Announces Restructuring and Continued Operations
December 1, 2023
 · 
1 min read
Deals
RVL Completes Financial Restructuring
November 27, 2023
 · 
3 min read
Deals
Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11
November 14, 2023
 · 
11 min read
Deals
RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
October 12, 2023
 · 
8 min read
Deals
Mallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial Restructuring Plan
October 10, 2023
 · 
8 min read
Deals
Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company
October 3, 2023
 · 
14 min read
Deals
Mallinckrodt Receives Court Approval for “First Day” Motions to Support Ongoing Operations
August 30, 2023
 · 
10 min read
Deals
Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations
August 28, 2023
 · 
13 min read
Deals
Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan
August 23, 2023
 · 
14 min read
Deals
Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business
August 10, 2023
 · 
5 min read
Deals
Amyris Announces Operational and Financial Restructuring to Advance Strategic Transformation
August 9, 2023
 · 
7 min read
Deals
Sorrento Therapeutics, Inc. Announces Auction for Sale of Scilex Securities and Bankruptcy Court Approval of Stalking Horse Bid
August 8, 2023
 · 
6 min read
Load More